Marci Lowe
Nurse Practitioner · Yukon, OKNPI 1295995827
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.4% of the total across 170 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 12.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,660, more than ten times the $164 reported in 2021. Among nurse practitioner clinicians in OK with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 170 payments — averaging $24.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$508
- Collegium Pharmaceutical, Inc.$498
- Medtronic$496
- Sanofi$473
- Amgen$335
- Corcept Therapeutics$325
- plus $2K from 23 others
What the payments were for
- Food & beverage$4,08798%
- Education$662%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 28 | $508 |
| Collegium Pharmaceutical, Inc. | 29 | $498 |
| Medtronic | 14 | $496 |
| Sanofi | 5 | $473 |
| Amgen(2 entities) | 17 | $335 |
| Corcept Therapeutics | 8 | $325 |
| AstraZeneca(2 entities) | 12 | $224 |
| UCB, Inc. | 9 | $180 |
| Bayer | 2 | $118 |
| IBSA Pharma Inc. | 7 | $105 |
| Jazz Pharmaceuticals Inc. | 1 | $100 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $83 |
| Novartis | 4 | $83 |
| Sanofi-aventis U.S. LLC | 1 | $82 |
| Scilex Pharmaceuticals Inc. | 4 | $75 |
| Johnson & Johnson | 4 | $71 |
| Azurity Pharmaceuticals, Inc. | 4 | $70 |
| Hikma Pharmaceuticals USA | 3 | $61 |
| Arbor Pharmaceuticals, Inc. | 3 | $40 |
| Valinor Pharma, LLC | 2 | $37 |
| Boston Scientific | 1 | $32 |
| Almatica Pharma LLC | 1 | $27 |
| ANI Pharmaceuticals, Inc. | 1 | $23 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $23 |
| Spinal Simplicity, LLC | 1 | $20 |
| Pacira Pharmaceuticals Incorporated | 1 | $17 |
| Redhill Biopharma Inc. | 1 | $17 |
| Protega Pharmaceutials Inc | 1 | $15 |
| Abbott | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,153 in reported general payments places this provider in the 90th percentile of 824 nurse practitioner providers in Oklahoma.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MovantikNaloxegol Oxalate | 21 | $12,960 |
| LinzessLinaclotide | 14 | $10,768 |
| BelbucaBuprenorphine Hcl | 13 | $9,838 |
| Buprenorphine | 41 | $9,395 |
| Pregabalin | 46 | $4,769 |
| Tramadol Hcl ErTramadol Hcl | 82 | $4,711 |
| Gabapentin | 250 | $3,648 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 149 | $3,503 |
| Tizanidine Hcl | 221 | $3,472 |
| Baclofen | 149 | $3,139 |
| Diclofenac Sodium | 26 | $2,534 |
| Doxepin Hcl | 13 | $2,363 |
| Buprenorphine Hcl | 85 | $2,258 |
| Cyclobenzaprine Hcl | 39 | $1,453 |
| Chlorzoxazone | 27 | $1,298 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Redhill Biopharma Inc.Movantik | $17 | $12,96021 claims |
| Hikma Pharmaceuticals USABuprenorphine, Buprenorphine Hcl | $61 | $11,653126 claims |
| AbbVieLinzess | $508 | $10,76814 claims |
| Collegium Pharmaceutical, Inc.Belbuca | $498 | $9,83813 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 824 nurse practitioner providers in Oklahoma.
Other nurse practitioner in Yukon
- Jenny GuthrieTulsa$106K
- Leah MeltonNorman$87K
- Sara GoreOklahoma City$52K
- Teisha GalleglyMoore$43K
- Stacy NewberryTulsa$28K
- Russell RoomsOklahoma City$24K
- Grant YoungOklahoma City$15K
- Monica LawsonNorman$15K
- Amanda SmallTulsa$14K
- Janelle WagnerOklahoma City$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.